Relay Therapeutics (RLAY) Enterprise Value (2019 - 2026)
Relay Therapeutics (RLAY) reported Enterprise Value of -$204.6 million for Q1 2026, down 118.71% year-over-year from $1.1 billion in Q1 2025, and down 143.51% quarter-over-quarter from -$84.0 million in Q4 2025.
Relay Therapeutics (RLAY) Enterprise Value (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 8 years of Enterprise Value data on file, last reported at -$204.6 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$204.6 million, down 118.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$204.6 million (down 118.71% YoY), and the FY2025 annual result was -$84.0 million, up 32.4% from the prior year.
- Enterprise Value declined to -$204.6 million in Q1 2026 per RLAY's latest filing, from -$84.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$84.0 million in Q4 2025 and troughed at -$354.6 million in Q3 2022.
- A 5-year average of -$146.3 million and a median of -$143.7 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value jumped 58.57% in 2022, then slumped 118.71% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$151.8 million in 2022, then advanced by 5.31% to -$143.7 million in 2023, then gained by 13.53% to -$124.3 million in 2024, then surged by 32.4% to -$84.0 million in 2025, then slumped by 143.51% to -$204.6 million in 2026.
- Business Quant data shows RLAY's Enterprise Value at -$204.6 million in Q1 2026, -$84.0 million in Q4 2025, and -$91.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | -204.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -204.59 Mn |
| Dec 31, 2025 | -84.02 Mn |
| Sep 30, 2025 | -91.56 Mn |
| Jun 30, 2025 | -113.94 Mn |
| Mar 31, 2025 | -93.54 Mn |
| Dec 31, 2024 | -124.29 Mn |
| Sep 30, 2024 | -152.36 Mn |
| Jun 30, 2024 | -134.13 Mn |
| Mar 31, 2024 | -152.87 Mn |
| Dec 31, 2023 | -143.74 Mn |
| Sep 30, 2023 | -151.33 Mn |
| Jun 30, 2023 | -145.90 Mn |
| Mar 31, 2023 | -161.28 Mn |
| Dec 31, 2022 | -151.79 Mn |
| Sep 30, 2022 | -354.64 Mn |
| Jun 30, 2022 | -107.74 Mn |
| Mar 31, 2022 | -119.45 Mn |
| Dec 31, 2021 | -280.12 Mn |
| Sep 30, 2021 | -228.56 Mn |
| Jun 30, 2021 | -260.07 Mn |